AAAAAA

   
Results: 1-20 |
Results: 20
Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens
Authors: Easterbrook, PJ Newson, R Ives, N Pereira, S Moyle, G Gazzard, BG
Citation: Pj. Easterbrook et al., Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens, J ACQ IMM D, 27(4), 2001, pp. 350-364
Interrupting antiretroviral treatment needs particular care
Authors: Sewell, WAC Mazhude, C Murdin-Geretti, A Jones, S Easterbrook, PJ
Citation: Wac. Sewell et al., Interrupting antiretroviral treatment needs particular care, BR MED J, 322(7286), 2001, pp. 616-616
The metabolic toxicities of antiretroviral therapy
Authors: Herman, JS Easterbrook, PJ
Citation: Js. Herman et Pj. Easterbrook, The metabolic toxicities of antiretroviral therapy, INT J STD A, 12(9), 2001, pp. 555-564
An association of disseminated Mycoplasma fermentans in HIV-1 positive patients with non-Hodgkin's lymphoma
Authors: Ainsworth, JG Easterbrook, PJ Clarke, J Gilroy, CB Taylor-Robinson, D
Citation: Jg. Ainsworth et al., An association of disseminated Mycoplasma fermentans in HIV-1 positive patients with non-Hodgkin's lymphoma, INT J STD A, 12(8), 2001, pp. 499-504
Incidence and risk factors for the development of indinavir-associated renal complications
Authors: Herman, JS Ives, NJ Nelson, M Gazzard, BG Easterbrook, PJ
Citation: Js. Herman et al., Incidence and risk factors for the development of indinavir-associated renal complications, J ANTIMICRO, 48(3), 2001, pp. 355-360
Cross-staining of cytotoxic T lymphocyte populations with peptide-MHC class I multimers of natural HIV-1 variant antigens
Authors: Oxenius, A Price, DA Dawson, SJ Tun, T Easterbrook, PJ Phillips, RE Sewell, AK
Citation: A. Oxenius et al., Cross-staining of cytotoxic T lymphocyte populations with peptide-MHC class I multimers of natural HIV-1 variant antigens, AIDS, 15(1), 2001, pp. 121-122
The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic
Authors: Ives, NJ Gazzard, BG Easterbrook, PJ
Citation: Nj. Ives et al., The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic, J INFECTION, 42(2), 2001, pp. 134-139
Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8+ T lymphocyte activation in response to therapeutic manipulation of virus load
Authors: Oxenius, A Gunthard, HF Hirschel, B Fidler, S Weber, JN Easterbrook, PJ Bell, JI Phillips, RE Price, DA
Citation: A. Oxenius et al., Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8+ T lymphocyte activation in response to therapeutic manipulation of virus load, EUR J IMMUN, 31(4), 2001, pp. 1115-1121
Mycoplasma species in rapid and slow HIV progressors
Authors: Ainsworth, JG Hourshid, S Easterbrook, PJ Gilroy, CB Weber, JN Taylor-Robinson, D
Citation: Jg. Ainsworth et al., Mycoplasma species in rapid and slow HIV progressors, INT J STD A, 11(2), 2000, pp. 76-79
The relationship of psychological variables and disease progression among long-term HIV-infected men
Authors: Thornton, S Troop, M Burgess, AP Button, J Goodall, R Flynn, R Gazzard, BG Catalan, J Easterbrook, PJ
Citation: S. Thornton et al., The relationship of psychological variables and disease progression among long-term HIV-infected men, INT J STD A, 11(11), 2000, pp. 734-742
Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic
Authors: Easterbrook, PJ Yu, LM Goetghebeur, E Boag, F McLean, K Gazzard, B
Citation: Pj. Easterbrook et al., Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic, AIDS, 14(5), 2000, pp. 561-571
Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8(+) and CD4(+) T lymphocytes
Authors: Oxenius, A Price, DA Easterbrook, PJ O'Callaghan, CA Kelleher, AD Whelan, JA Sontag, G Sewell, AK Phillips, RE
Citation: A. Oxenius et al., Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8(+) and CD4(+) T lymphocytes, P NAS US, 97(7), 2000, pp. 3382-3387
Acid-alcohol fast bacilli in sputa of HIV-infected patients
Authors: Sullivan, AK Hannan, MM Azadian, BS Easterbrook, PJ Gazzard, BG Nelson, MR
Citation: Ak. Sullivan et al., Acid-alcohol fast bacilli in sputa of HIV-infected patients, INT J STD A, 10(9), 1999, pp. 606-608
Are HIV-infected patients with rapid CD4 cell decline a subgroup who benefit from early antiretroviral therapy?
Authors: Easterbrook, PJ Goodall, RL Babiker, AG Yu, LM Smith, D Cooper, DA Gazzard, BG
Citation: Pj. Easterbrook et al., Are HIV-infected patients with rapid CD4 cell decline a subgroup who benefit from early antiretroviral therapy?, J ANTIMICRO, 43(3), 1999, pp. 379-388
Long-term non-progression in HIV infection: Definitions and epidemiological issues
Authors: Easterbrook, PJ
Citation: Pj. Easterbrook, Long-term non-progression in HIV infection: Definitions and epidemiological issues, J INFECTION, 38(2), 1999, pp. 71-73
Cytotoxic T lymphocytes and viral evolution in primary HIV-I infection
Authors: Price, DA O'Callaghan, CA Whelan, JA Easterbrook, PJ Phillips, RE
Citation: Da. Price et al., Cytotoxic T lymphocytes and viral evolution in primary HIV-I infection, CLIN SCI, 97(6), 1999, pp. 707-718
Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease
Authors: Kirchhoff, F Easterbrook, PJ Douglas, N Troop, M Greenough, TC Weber, J Carl, S Sullivan, JL Daniels, RS
Citation: F. Kirchhoff et al., Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease, J VIROLOGY, 73(7), 1999, pp. 5497-5508
Chemokine receptor polymorphisms and human immunodeficiency virus disease progression
Authors: Easterbrook, PJ Rostron, T Ives, N Troop, M Gazzard, BG Rowland-Jones, SL
Citation: Pj. Easterbrook et al., Chemokine receptor polymorphisms and human immunodeficiency virus disease progression, J INFEC DIS, 180(4), 1999, pp. 1096-1105
Superbugs: are we at the threshold of a new Dark Age?
Authors: Easterbrook, PJ
Citation: Pj. Easterbrook, Superbugs: are we at the threshold of a new Dark Age?, HOSP MED, 59(7), 1998, pp. 524
Efavirenz - A viewpoint
Authors: Easterbrook, PJ
Citation: Pj. Easterbrook, Efavirenz - A viewpoint, DRUGS, 56(6), 1998, pp. 1065-1065
Risultati: 1-20 |